Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence

Toshihiko Goto1, Shohei Kikuchi2, Yomei Sakurai2

  • 1Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; t-goto@med.nagoya-cu.ac.jp.

Insights

Chronotropic incompetence (CTI) involves impaired heart rate response during exercise. This study found higher hydroxyephedrine retention in CTI patients, suggesting presynaptic sympathetic nerve dysfunction contributes to this condition.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Neuroscience

Background:

  • Chronotropic incompetence (CTI) limits exercise capacity and predicts mortality.
  • Previous research indicated postsynaptic sympathetic dysfunction in CTI patients without heart failure (HF).
  • Cardiac presynaptic sympathetic nervous system function in CTI remains poorly understood.

Purpose of the Study:

  • To investigate cardiac presynaptic sympathetic nervous system function in patients with CTI but no HF.
  • Utilized 11C-hydroxyephedrine Positron Emission Tomography (PET) to assess presynaptic function.

Main Methods:

  • Cardiac PET with 11C-hydroxyephedrine was performed on 13 CTI patients and 9 healthy controls.
  • Measured the global hydroxyephedrine retention index, reflecting presynaptic sympathetic activity.
  • CTI was defined as failing to achieve 80% of heart rate reserve during exercise.

Main Results:

  • No significant differences in clinical or echocardiographic parameters between groups.
  • CTI patients exhibited significantly lower peak heart rates compared to controls.
  • A significantly higher global hydroxyephedrine retention index was observed in CTI patients.

Conclusions:

  • Patients with CTI without HF show elevated hydroxyephedrine retention.
  • Impaired norepinephrine release from presynaptic sympathetic nerves is a potential mechanism underlying CTI.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
530
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.6K